SCHEMBL19953850

SCHEMBL19953850

c1ccc(-c2ccc(-c3cc(-c4ccccc4)c4cc(-c5ccc6nc(-c7ccc(-c8ccccc8)cc7)cc(-c7ccccc7)c6c5)ccc4n3)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
KDM4E B2RXH2 4/20 0.59
MAPT P10636 4/20 0.59
LMNA P02545 2/20 0.59
NPSR1 Q6W5P4 2/20 0.59
MAPK1 P28482 2/20 0.59
MEN1 O00255 1/20 0.59
RECQL P46063 1/20 0.59
KMT2A Q03164 1/20 0.59
AURKA O14965 1/20 0.57
AURKB Q96GD4 1/20 0.57
ACACA Q13085 3/20 0.57
ELANE P08246 1/20 0.55
PIK3CA P42336 1/20 0.54
ESR1 P03372 1/20 0.54
ESR2 Q92731 1/20 0.54
HPGD P15428 4/20 0.52
HSP90AA1 P07900 1/20 0.52
DHODH Q02127 2/20 0.51
TOP1 P11387 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13774335 1.00 ALDH1A1 (0.59) ALDH1A1KDM4EMAPTLMNANPSR1
SCHEMBL14666153 0.98 ALDH1A1 (0.61) ALDH1A1KDM4EMAPTLMNANPSR1
SCHEMBL19618369 0.95 ALDH1A1 (0.55) ALDH1A1KDM4EMAPTLMNANPSR1
SCHEMBL19618340 0.95 ALDH1A1 (0.55) ALDH1A1KDM4EMAPTLMNANPSR1
SCHEMBL19618344 0.95 ALDH1A1 (0.55) ALDH1A1KDM4EMAPTLMNANPSR1
SCHEMBL19618420 0.95 ALDH1A1 (0.55) ALDH1A1KDM4EMAPTLMNANPSR1
SCHEMBL19618390 0.93 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTLMNANPSR1
SCHEMBL19618376 0.93 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTLMNANPSR1
SCHEMBL19618332 0.93 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTLMNANPSR1
SCHEMBL19618458 0.93 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTLMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11165035-B2 Organic electroluminescent device emitting blue light CYNORA GMBH (DE) 2021-11-02 US disclosed
US-20190177303-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-06-13 US disclosed
US-9917270-B1 Organic electroluminescent device having an exciton quenching layer CYNORA GMBH (DE) 2018-03-13 US disclosed
US-9917270-B1 Organic electroluminescent device having an exciton quenching layer CYNORA GMBH (DE) 2018-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190177303-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, ORC3, OR51E2 ALDH1A1 542/4885KDM4E 4001/4885MAPT 3572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.